Evaluation of Glutathione Peroxidase 4 role in Preeclampsia

Xinguo Peng1, Yan Lin2, Jinling Li1

  • 1Clinical Laboratory, Binzhou Medical University Hospital, Binzhou, China.

Scientific Reports
|September 20, 2016
PubMed

Insights

Genetic variations in Glutathione Peroxidase 4 (GPx4), specifically the rs713041 polymorphism, are associated with an increased risk of preeclampsia (PE) in Chinese Han women. This finding highlights GPx4

Area of Science:

  • Genetics
  • Obstetrics
  • Biochemistry

Background:

  • Preeclampsia (PE) is a serious pregnancy complication.
  • Oxidative stress is implicated in PE pathogenesis.
  • Glutathione Peroxidase 4 (GPx4) is a key antioxidant enzyme.

Purpose of the Study:

  • To investigate the association between GPx4 gene polymorphisms and PE susceptibility in Chinese Han women.
  • To explore the role of GPx4 in PE development.

Main Methods:

  • Genotyping of GPx4 polymorphisms (rs713041 and rs4807542) using TaqMan allelic discrimination real-time PCR.
  • Case-control study involving 1008 PE patients and 1386 controls.

Main Results:

  • Significant differences in genotypic and allelic frequencies of rs713041 were observed between PE patients and controls.
  • The C allele of rs713041 was associated with a higher risk of PE.
  • rs713041 genotype was linked to mild, severe, and early-onset PE.

Conclusions:

  • The rs713041 polymorphism in the GPx4 gene may play a significant role in the pathogenesis of preeclampsia.
  • GPx4 genetic variations could be potential biomarkers for PE risk assessment.